Global Leader with 15 years of experience in Pharmaceutical Industry, specializing in Pricing and Market Access, driving successful commercialization of Oncology & Specialty Care innovations across key global markets. Expertise spans value-based pricing, marketing, evidence generation, launch and commercialization, GA and stakeholder engagement, ensuring therapies achieve sustainable market access and deliver meaningful impact to patients. Proven ability to navigate complex healthcare systems, develop robust access strategies, and align cross-functional teams to optimize product positioning. Adept at shaping payer value narratives, integrating real-world evidence into access strategies, and leading high-level negotiations with global stakeholders.
Focused on bridging scientific innovation with market realities to maximize patient access, commercial success, and long-term healthcare sustainability.

Boehringer Ingelheim is a family-owned company that has been transforming lives in healthcare since 1885. Its approximately 54,500 employees in 130 markets create value through innovation by infusing long-term, sustainable thinking into our Human Pharma and Animal Health units. The company acknowledges the deep and complex ways the lives of humans and animals are interconnected, works on breakthrough therapies, committed to groundbreaking pharmaceutical innovation across our three business units Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing, co-creating solutions that help millions of people worldwide live longer, healthier lives.